[Question of the European Agency of Drugs (EMEA): interaction between drotrecogin alfa (activated) and heparin in prophylactic dose]

Ann Fr Anesth Reanim. 2003 Dec:22 Spec No 1:23-7.
[Article in French]
No abstract available

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Drug Interactions
  • Europe
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / pharmacology
  • Government Agencies*
  • Heparin / administration & dosage*
  • Heparin / pharmacology
  • Humans
  • Protein C / pharmacology*
  • Recombinant Proteins / pharmacology*
  • Regression Analysis
  • Time Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Fibrinolytic Agents
  • Protein C
  • Recombinant Proteins
  • Heparin
  • drotrecogin alfa activated